Actions

Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.


View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
Crop Life Science Ltd (CLSL) is currently trading at 78.80 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
Crop Life Science Limited is a leading Indian manufacturer of agro chemical formulations, including fungicides, herbicides, insecticides, and plant growth regulators. The company operates a manufacturing facility at GIDC Ankleshwar, Gujarat. Since its inception, Crop Life Science has expanded its product range significantly and started exporting pesticides to countries like Indonesia, Bangladesh, and Egypt. It now offers over 85 agro chemical products. In 2021, the company inaugurated a Biological Research and Development Laboratory, indicating a strong focus on innovation and product development. Crop Life Science's recent IPO in August 2023 raised Rs 27 Crore, suggesting strategic funding aimed at further expansion and resource optimization. The acquisition of Hetban Spechem Limited as a subsidiary in March 2024 signifies strategic efforts towards diversification and increased production capacity.
Over the past 52 weeks, Crop Life Science Ltd has traded between a low of ₹39.05 and a high of ₹92.25. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
Crop Life Science Ltd has a market capitalization of approximately 135.15. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
Crop Life Science Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 20.35 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 135.15 Cr, Crop Life Science Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
Crop Life Science Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of Crop Life Science Ltd is 20.35. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
Bearish
3
Neutral
5
Bullish
6
Bearish
18
Neutral
9
Bullish
19
Bearish
15
Neutral
4
Bullish
13
Bearish
3
Neutral
5
Bullish
6
Bearish
3
Neutral
5
Bullish
6
Bearish
15
Neutral
4
Bullish
13
Bearish
15
Neutral
4
Bullish
13
Bearish
15
Neutral
4
Bullish
13

Industrial Manufacturing
Industrial Products
135 Cr
Moderate Risk
20.4
46.7
1.0
1.6
92.25
39.05
Sales CAGR
Profit CAGR
ROE
ROCE